Seeking Alpha

Medgenics (MDGN +13.2%) gets a pop today after being granted a patent by the USPTO protecting...

Medgenics (MDGN +13.2%) gets a pop today after being granted a patent by the USPTO protecting the use of the company's Epodure Biopump technology for the treatment of anemia. The patent agency also allowed claims covering a similar method for delivery underlying it's Hemodure Biopump technology for sustained prophylactic treatment of hemophilia. MDGN's global portfolio now includes 36 patents issued, with 81 more pending.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)